Literature DB >> 9413650

Influence of body size and age on mitral ring motion.

B Wandt1, L Bojö, B Wranne.   

Abstract

Left ventricular systolic and diastolic function can be assessed by studying mitral ring motion. Reference values for a wide range of age and body size are lacking however. The motion of the mitral ring was studied with M-mode echocardiography using the apical four- and two-chamber views. Data are reported as the average of measurements of four points on the mitral ring. Data were analysed using the stepwise multiple regression technique, with age, gender, height, weight, body surface area and heart rate as independent variables. A total of 70 healthy subjects were studied. In children and adolescents under age 18, there was strong correlation between mitral ring motion and body size, age and heart rate. The ring motion was best described as mitral ring motion (mm) = 2.2 + 0.078 x height (cm) (SEE = 1.0 mm). In adults, mitral ring motion was correlated with age, height and heart rate but not with weight or body surface area. Ring motion could be described from the following equations: mitral ring motion (mm) = 12.7 - 0.060 x age (years) + 0.031 x height (cm) (SEE = 1.2) or, if only age is taken into account, mitral ring motion = 18.4 - 0.065 x age (SEE = 1.2). In both children and adolescents up to age 18 and in adults, atrial contribution correlated significantly and positively to age and inversely to heart rate but not to height, weight, body surface area or gender. Atrial contribution was best described by the equation: atrial contribution = 0.15 + 0.0039 x age (SEE = 0.027). Thus, age and body size influences mitral ring motion and should be taken into account when interpreting patient data.

Entities:  

Mesh:

Year:  1997        PMID: 9413650     DOI: 10.1046/j.1365-2281.1997.00065.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  8 in total

1.  Mitral annulus motion versus long-axis fractional shortening.

Authors:  Kent Emilsson; Rigmor Egerlid; Britt-Marie Nygren; Birger Wandt
Journal:  Exp Clin Cardiol       Date:  2006

2.  Can the amplitude of mitral annulus motion be used in the assessment of left ventricular systolic function in patients with left ventricular wall thickness in the upper limit of normal to mild hypertrophy?

Authors:  Kent Emilsson
Journal:  Exp Clin Cardiol       Date:  2003

3.  Echocardiographic assessment of ejection fraction in left ventricular hypertrophy.

Authors:  B Wandt; L Bojö; K Tolagen; B Wranne
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

4.  Left atrioventricular plane displacement but not left ventricular ejection fraction is influenced by the degree of aortic stenosis.

Authors:  E Rydberg; P Gudmundsson; L Kennedy; L Erhardt; R Willenheimer
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

5.  Robotic tissue tracking for beating heart mitral valve surgery.

Authors:  Shelten G Yuen; Nikolay V Vasilyev; Pedro J del Nido; Robert D Howe
Journal:  Med Image Anal       Date:  2010-07-06       Impact factor: 8.545

6.  Cardiac function in relation to rhythm outcome after intraoperative epicardial left atrial cryoablation.

Authors:  Birgitta Johansson; Birgitta Houltz; Nils Edvardsson; Henrik Scherstén; Thomas Karlsson; Birger Wandt; Eva Berglin
Journal:  Scand Cardiovasc J       Date:  2011-08-05       Impact factor: 1.589

7.  Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images.

Authors:  Felicia Seemann; Ulrika Pahlm; Katarina Steding-Ehrenborg; Ellen Ostenfeld; David Erlinge; Jean-Luc Dubois-Rande; Svend Eggert Jensen; Dan Atar; Håkan Arheden; Marcus Carlsson; Einar Heiberg
Journal:  BMC Med Imaging       Date:  2017-02-28       Impact factor: 1.930

8.  State diagrams of the heart--a new approach to describing cardiac mechanics.

Authors:  Matilda Larsson; Anna Bjällmark; Jonas Johnson; Reidar Winter; Lars-Ake Brodin; Stig Lundbäck
Journal:  Cardiovasc Ultrasound       Date:  2009-05-27       Impact factor: 2.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.